Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), sold 17,100 shares at $90.74 ($1.6M) on 2023-05-09, disclosed to the SEC on 2023-05-11.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-04-21 | $714K | — | Filing → |